OSOBio - Risk-based Manufacture of Pharmaceutical Products A guide to Risk MaPP approaches and experience

October 24, 2011

Article

OSOBio - Risk-based Manufacture of Pharmaceutical Products A guide to Risk MaPP approaches and experience

Recent Videos

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Related Content

A laboratory technician performing a quality control test on a batch of pharmaceutical tablets, highlighting the importance of ensuring drug safety. | Image Credit: ©MAY -stock.adobe.com

Poor API Quality Threatens a Healthy Supply

Poor API quality may often lead to delays in production and a shortage of supply.

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific

March 28th 2025

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Supporting Merck toward a new age of aseptic fill-finish processing of highly potent drugs.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific

March 28th 2025

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

From Thema4 to TH5: The Evolution of Fedegari’s Autoclaves

An article describing the technological advancement from one process controller to the new one.

Related Content

A laboratory technician performing a quality control test on a batch of pharmaceutical tablets, highlighting the importance of ensuring drug safety. | Image Credit: ©MAY -stock.adobe.com

Poor API Quality Threatens a Healthy Supply

Poor API quality may often lead to delays in production and a shortage of supply.

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific

March 28th 2025

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Supporting Merck toward a new age of aseptic fill-finish processing of highly potent drugs.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific

March 28th 2025

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

From Thema4 to TH5: The Evolution of Fedegari’s Autoclaves

An article describing the technological advancement from one process controller to the new one.

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.